The underlying biochemical defect in diabetes insipidus is a functional deficiency, or even a total absence, of ADH. The etiology ranges from congenital anomalies to malignant disease or even head trauma. With recognition that a number commonly used drugs either stimulate or inhibit ADH secretion and action, therapy of both diabetes insipidus and of inappropriate ADH secretion has been facilitated.
No takes yet. Share an insight, caveat, or question.
Arnold M. Moses (1977) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: